IBIO (iBio, Inc.) Pangali Forward P/E
iBio, Inc. (IBIO) generates net profit through research centers in Texas and California, utilizing external bio-factories. The company's valuation based on forward P/E clearly demonstrates the asset's dynamics, where the current parameter equals 0.00. Financial success is based on future licenses and AI-driven antibody modeling. A flawless scientific image makes the company a reliable partner for the rapid release of vaccines on a plant-based platform.
Rincian analitis perusahaan iBio, Inc.
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- rincian utang lan likuiditas:
- indikator profitabilitas perusahaan lan kelipatan valuasi:
IBIO - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep iBio, Inc.|IBIO - Periode bali modal bisnis|Rega marang bathi mangsa ngarep iBio Corp|IBIO - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan iBio Inc|IBIO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) iBio|IBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ibioinc.com|IBIO - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep iBio, Inc.
Ringkesan analitik perusahaan:iBio
The high scientific reputation of iBio, Inc. (IBIO) in the field of AI antibody engineering and immunotherapy drives market expectations for the issuer's future earnings. By analyzing the forward P/E based on company analyst estimates, investors correlate the current share price with expected net income, where deviations from industry averages signal either an overvaluation of the asset or hidden growth potential, directly impacting the stability of the invested capital.
Pesaing iBio, Inc. (IBIO)
Prakiraan rega marang bathi ARGX (argenx)|BNTX (BioNTech Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (abivax.com)|Kapitalisasi marang proyeksi bathi ADMA Corp (ADMA)|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|Kiniksa (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols SA|Prakiraan rega marang bathi ADPT|Pangali Forward P/E Celldex Corp|Rega marang bathi mangsa ngarep Aurinia Pharmaceuticals (AUPH)|biocryst.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Rasio prakiraan rega marang bathi|Pharvaris Corp - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi AbCellera Biologics ABCL|TRML: Pangali Forward P/E|PGEN (precigen.com) - Rega marang bathi mangsa ngarep|PHAR (Pharming Group) - Pangali Forward P/E|Nektar Therapeutics Inc (NKTR) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Upstream Bio Corp (UPB)|ZBIO - Rasio prakiraan rega marang bathi|Immunome, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi GOSS|KalVista Pharmaceuticals, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep SVRA|RIGL (Rigel Pharmaceuticals) - Pangali Forward P/E|Prakiraan rega marang bathi anaptysbio.com (ANAB)|Prakiraan rega marang bathi ATXS (Astria Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi enGene Holdings Inc|Pangali Forward P/E RAPT (RAPT Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Aerovate Therapeutics, Inc. (JBIO)|Aclaris Therapeutics - Pangali Forward P/E|KYTX: Rega marang bathi mangsa ngarep|TLSA: Pangali Forward P/E|CABA - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Ventyx Bio|Rasio prakiraan rega marang bathi Theratechnologies, Inc THTX|Rega marang bathi mangsa ngarep Avalo Therapeutics, Inc (AVTX)|ELDN: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E AGEN (Agenus Inc.)|Pangali mangsa ngarep rega marang bathi CLYM|Zura Bio Limited - Pangali Forward P/E|ATYR - Pangali Forward P/E|adagene.com (ADAG) - Rega marang bathi mangsa ngarep|Ikena Oncology - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Shattuck Labs Inc|Prakiraan rega marang bathi Equillium Bio (EQ)|Pangali Forward P/E CNTB|Pangali Forward P/E immunic-therapeutics.com (IMUX)|Atara Bio - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi IFRX|X4 Pharmaceuticals, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Adicet Bio ACET|celularity.com (CELU) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi INmune Bio Corporation|Rega marang bathi mangsa ngarep Barinthus Biotherapeutics|Prakiraan rega marang bathi kezarlifesciences.com (KZR)|Prakiraan rega marang bathi SABS (SAB Biotherapeutics, Inc.)|Pangali Forward P/E Akari Therapeutics PLC (AKTX)|Rega marang bathi mangsa ngarep Enlivex Therapeutics Ltd. ENLV|QTTB: Rasio rega marang bathi mangsa ngarep|GeoVax Labs, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi edesabiotech.com|CARM: Pangali Forward P/E|XTLB - Kapitalisasi marang proyeksi bathi|BOLT (Bolt Biotherapeutics Inc.) - Pangali Forward P/E|Rega marang bathi mangsa ngarep HCWB|Pangali Forward P/E APVO|Kapitalisasi marang proyeksi bathi AIM ImmunoTech, Inc.|Rega marang bathi mangsa ngarep Aditxt, Inc. ADTX|GRI Bio Inc (GRI) - Rasio prakiraan rega marang bathi|XRTX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi HIND (Vyome Therapeutics)|REVB: Pangali Forward P/E|INDP - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Scinai Immunotherapeutics Ltd.|Rasio rega marang bathi mangsa ngarep CALI (CalciMedica Corp)|Pangali Forward P/E AFMD|Prakiraan rega marang bathi allakos.com ALLK|HOOKIPA Pharma - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi IGM Biosciences Inc. (IGMS)|iTeos Therapeutics, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Ocean Biomedical Inc OCEA|TCBP: Pangali Forward P/E|THRD (Third Harmonic Bio Inc) - Rega marang bathi mangsa ngarep
